Cell biology platforms

Fully automated platforms

Fluofarma is one of the first Contract Research Organizations that from its inception has specialized in High Content Screening (HCS).

Fluofarma has set up an array of High Content Screening platforms including:

Automated Flow Cytometry
Automated Confocal Microscopy
Laser Scanning Cytometry

  High Content Screening Platform

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS